Antibody Therapeutics, the official journal of Chinese Antibody Society, published by Oxford University Press, has been accepted by Clarivate for indexing in the Emerging Sources Citation Index (ESCI). This means that all content published in Antibody Therapeutics will now be indexed in Web of Science, providing greater discoverability and dissemination of content for authors.

Launched in November 2015, ESCI is an independent citation index database within Web of Science aimed at indexing high-quality, peer-reviewed academic journals and conference proceedings of regional significance and emerging scientific fields. Antibody Therapeutics indexed by ESCI means that the journal will have its first impact factor by the end of June 2025, and all papers published from now on will be indexed by Web of Science.

Launched in 2018, Antibody Therapeutics has already been indexed by Scopus database and obtained its first CiteScore in 2019. Since then, its CiteScore has continuously grown each year (1.0 in 2019; 2.9 in 2020; 5.7 in 2021; 6.4 in 2022; and 8.7 in 2023). In additional, Antibody Therapeutics has also been indexed by PubMed under U.S. National Library of Medicine (NLM) since 2021 and other major databases of scientific journals including DOAJ.

About Antibody Therapeutics
Antibody Therapeutics, the official journal of Chinese Antibody Society, is an open-access, peer-reviewed international journal published by Oxford University Press. Antibody Therapeutics aims to provide a platform for publishing and sharing the latest advancements in the field of therapeutic antibody research. The journal accepts original research articles, reviews, and methodological papers, and it is indexed by several well-known international databases, including ESCI, Scopus, and PubMed. The editorial board consists of over 30 renowned experts in the antibody field from more than five countries (regions) representing various academic and corporate research institutions. The editor-in-chief is Professor Mitchell Ho at the National Cancer Institute of the National Institutes of Health (NIH).

For more information, please visit the Antibody Therapeutics’ official website: https://academic.oup.com/abt.